These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23163317)

  • 41. Catalytic activation of N-N multiple bonds: a homogeneous palladium catalyst for mechanistically unprecedented reduction of azo compounds.
    Muñiz K; Nieger M
    Angew Chem Int Ed Engl; 2006 Mar; 45(14):2305-8. PubMed ID: 16518789
    [No Abstract]   [Full Text] [Related]  

  • 42. Molecular microencapsulation for in vivo transport of water-insoluble drugs.
    Hernandez-Valdepeña I; Braud C; Coudane J; Domurado D; Vert M
    J Control Release; 2005 Jan; 101(1-3):296-7. PubMed ID: 15678609
    [No Abstract]   [Full Text] [Related]  

  • 43. Microbially controlled drug delivery to the colon.
    Rubinstein A
    Biopharm Drug Dispos; 1990; 11(6):465-75. PubMed ID: 2207298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site.
    Liu Z; Li Y; Chen H; Lai HT; Wang P; Wu SY; Wold EA; Leonard PG; Joseph S; Hu H; Chiang CM; Brasier AR; Tian B; Zhou J
    J Med Chem; 2022 Feb; 65(3):2388-2408. PubMed ID: 34982556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Redox-Sensitive Linear and Cross-Linked Cystamine-Based Polymers for Colon-Targeted Drug Delivery: Design, Synthesis, and Characterisation.
    Ng YM; Mat Yusuf SNA; Chiu HI; Lim V
    Pharmaceutics; 2020 May; 12(5):. PubMed ID: 32443633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoparticulate Drug Delivery Systems Targeting Inflammation for Treatment of Inflammatory Bowel Disease.
    Zhang S; Langer R; Traverso G
    Nano Today; 2017 Oct; 16():82-96. PubMed ID: 31186671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets.
    Taghipour YD; Bahramsoltani R; Marques AM; Naseri R; Rahimi R; Haratipour P; Iranpanah A; Panah AI; Farzaei MH; Abdollahi M
    Daru; 2018 Dec; 26(2):229-239. PubMed ID: 30382546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.
    Qiao H; Fang D; Chen J; Sun Y; Kang C; Di L; Li J; Chen Z; Chen J; Gao Y
    Drug Deliv; 2017 Nov; 24(1):233-242. PubMed ID: 28156160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel salicylazo polymers for colon drug delivery: dissolving polymers by means of bacterial degradation.
    Saphier S; Karton Y
    J Pharm Sci; 2010 Feb; 99(2):804-15. PubMed ID: 19603504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the colonic bacterial metabolism of azo-bonded prodrugsof 5-aminosalicylic acid.
    Sousa T; Yadav V; Zann V; Borde A; Abrahamsson B; Basit AW
    J Pharm Sci; 2014 Oct; 103(10):3171-5. PubMed ID: 25091594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of azo polymers for colon-specific drug delivery.
    Van den Mooter G; Maris B; Samyn C; Augustijns P; Kinget R
    J Pharm Sci; 1997 Dec; 86(12):1321-7. PubMed ID: 9423139
    [No Abstract]   [Full Text] [Related]  

  • 52. Bacterial reduction as means for colonic drug delivery: can other chemical groups provide an alternative to the azo bond?
    Saphier S; Haft A; Margel S
    J Med Chem; 2012 Dec; 55(23):10781-5. PubMed ID: 23163317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.